Inventor · disambiguated record
Nicholas Cooper
Also filed as: COOPER NICHOLAS · COOPER NICHOLAS A · COOPER NICHOLAS ANDREW
5 granted patents·10 pending applications·12 citations·filing 2017–2025
70Inventor score
Files withALTO NEUROSCIENCE INC8COOPER NICHOLAS2FRANKLIN ELECTRIC CO INC2ZAMBRISKI SHARON ANN2STATE FARM MUTUAL AUTOMOBILE INSURANCE CO1
Top patents by PatentIndex Score
15 records- 0178US12233059B2Effective treatment of depression in patients having impaired learning and/or memory or certain EEG characteristics with a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2024·Granted Feb 25, 2025·0 cites·20 claims
- 0275US12208096B2Effective treatment of depression in patients having impaired learning and/or memory or certain EEG characteristics with a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2024·Granted Jan 28, 2025·0 cites·12 claims
- 0374US10420387B2Exercise performance monitoring apparatusZAMBRISKI SHARON ANN·Filed 2017·Granted Sep 24, 2019·9 cites·22 claims
- 0472US10454267B1Motor protection device and method for protecting a motorFRANKLIN ELECTRIC CO INC·Filed 2018·Granted Oct 22, 2019·3 cites·21 claims
- 0570US2025009738A1Effective treatment of depression in patients having impaired learning and/or memory or certain eeg characteristics with a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2024·Application pending·0 cites
- 0664US2025144092A1Treatment of psychiatric or neurological disorders in patients with prominent anhedonia using irdabisant as a monotherapy or in combination with an antipsychotic agentALTO NEUROSCIENCE INC·Filed 2024·Application pending·0 cites
- 0763US2024316016A1Effective treatment of depression in patients having impaired learning and/or memory or certain eeg characteristics with a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2024·Application pending·0 cites
- 0861US2024307378A1Effective treatment of depression in patients having impaired learning and/or memory or certain eeg characteristics with a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2024·Application pending·0 cites
- 0959US2024197721A1Effective treatment of depression in patients having impaired learning and/or memory or certain eeg characteristics with a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2023·Application pending·0 cites
- 1058US2025177387A1Effective treatment of depression in patients having impaired learning and/or memory or certain eeg characteristics with a benzylpiperazine-aminopyridine agentALTO NEUROSCIENCE INC·Filed 2025·Application pending·0 cites
- 1152US11811273B2Motor protection device and method for protecting a motorFRANKLIN ELECTRIC CO INC·Filed 2020·Granted Nov 7, 2023·0 cites·18 claims
- 1249US2024289103A1Virtual assistant with conversion and analysis capabilitiesSTATE FARM MUTUAL AUTOMOBILE INSURANCE CO·Filed 2023·Application pending·0 cites
- 1345US2020352812A1Traction DeviceCOOPER NICHOLAS·Filed 2020·Application pending·0 cites
- 1440US2018177720A1Chewable Composition and Delivery PouchCOOPER NICHOLAS·Filed 2017·Application pending·0 cites
- 1534US2022288454A1Exercise Performance Monitoring GloveZAMBRISKI SHARON ANN·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicholas Cooper files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →